Literature DB >> 10609123

Immunology of type 1 diabetes. Intervention and prevention strategies.

S Bertera1, A Alexander, N Giannoukakis, P D Robbins, M Trucco.   

Abstract

Type 1 diabetes is the outcome of a progressive and selective destruction of insulin-producing cells in the pancreatic islets of Langerhans. The precise cause and mechanism(s) that trigger the insulin-producing cell destruction are still unclear, although it is well accepted that an autoimmune process plays a central role in diabetes development among genetically susceptible children. Additionally, certain viral infections, especially those caused by Coxsackievirus B, have been associated with the onset of type 1 diabetes. Possible gene therapy-based prevention and intervention strategies are discussed, based on the most accepted models of type 1 diabetes pathogenesis.

Entities:  

Mesh:

Year:  1999        PMID: 10609123     DOI: 10.1016/s0889-8529(05)70105-5

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  6 in total

Review 1.  Overview of prevention and intervention trials for type 1 diabetes.

Authors:  Jorge Daaboul; Desmond Schatz
Journal:  Rev Endocr Metab Disord       Date:  2003-12       Impact factor: 6.514

2.  A combination dual-sized microparticle system modulates dendritic cells and prevents type 1 diabetes in prediabetic NOD mice.

Authors:  Jamal S Lewis; Natalia V Dolgova; Ying Zhang; Chang Qing Xia; Clive H Wasserfall; Mark A Atkinson; Michael J Clare-Salzler; Benjamin G Keselowsky
Journal:  Clin Immunol       Date:  2015-04-02       Impact factor: 3.969

3.  Toward testing the hypothesis that group B coxsackieviruses (CVB) trigger insulin-dependent diabetes: inoculating nonobese diabetic mice with CVB markedly lowers diabetes incidence.

Authors:  S Tracy; K M Drescher; N M Chapman; K-S Kim; S D Carson; S Pirruccello; P H Lane; J R Romero; J S Leser
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

4.  Increased galectin-1 expression in muscle of Astragalus polysaccharide-treated Type 1 diabetic mice.

Authors:  Xingjian Zhou; Yancheng Xu; Guoming Yang; Fang Li
Journal:  J Nat Med       Date:  2011-03-20       Impact factor: 2.343

5.  Suppression of autoimmune diabetes by soluble galectin-1.

Authors:  Marcelo J Perone; Suzanne Bertera; William J Shufesky; Sherrie J Divito; Angela Montecalvo; Alicia R Mathers; Adriana T Larregina; Mabel Pang; Nilufer Seth; Kai W Wucherpfennig; Massimo Trucco; Linda G Baum; Adrian E Morelli
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

6.  Effect of pioglitazone on the course of new-onset type 1 diabetes mellitus.

Authors:  Kimberly Sue Tafuri; Mushtaq Ahmed Godil; Andrew Harry Lane; Thomas Allen Wilson
Journal:  J Clin Res Pediatr Endocrinol       Date:  2013
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.